A 16-week open-label study on the efficacy and safety of canakinumab treatment in urticarial vasculitis

被引：0
|
作者：
Krause, K. [1 ]
Mahamed, A. [1 ]
Maurer, M. [1 ]
机构：
[1] Charit Univ Med Berlin, Dept Dermatol & Allergy, D-10117 Berlin, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2013年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E12 / E12
页数：1
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES: AN OPEN-LABEL, PHASE-III, EXTENSION STUDY
    Brogan, P. A.
    Hofer, M.
    Kuemmerle-Deschner, J. B.
    Lauwerys, B.
    Speziale, A.
    Leon, K.
    Wei, X.
    Laxer, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 620 - 621
  • [22] The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson's disease psychosis: a 16-week, single-arm, open-label study
    Evidente, Virgilio G. H.
    DeKarske, Daryl
    Coate, Bruce
    Abler, Victor
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [23] Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period
    Seino, Yutaka
    Sasaki, Takashi
    Fukatsu, Atsushi
    Imazeki, Hisae
    Ochiai, Hidekazu
    Sakai, Soichi
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 981 - 994
  • [24] Safety and efficacy of rivastigmine in adolescents with Down syndrome: A preliminary 20-week, open-label study
    Heller, James H.
    Spiridigliozzi, Gail A.
    Crissman, Blythe G.
    Sullivan, Jennifer A.
    Eells, Rebecca L.
    Li, Jennifer S.
    Doraiswamy, P. Murali
    Krishnan, K. Ranga
    Kishnani, Priya S.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 755 - 765
  • [25] Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study
    Edwards, Keith
    Royall, Donald
    Hershey, Linda
    Lichter, David
    Hake, Ann
    Farlow, Martin
    Pasquier, Florence
    Johnson, Stewart
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 23 (06) : 401 - 405
  • [26] Safety and efficacy of etanercept treatment in children and adolescents with plaque psoriasis: 96-week results of open-label extension study
    Paller, Amy
    Pariser, David
    Siegfried, Elaine
    Kricorian, Gregory
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB11 - AB11
  • [27] Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension
    Kadowaki, Takashi
    Muto, Satsuki
    Ouchi, Yoshiumi
    Shimazaki, Ryutaro
    Seino, Yutaka
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (18) : 1903 - 1919
  • [28] Therapeutic efficacy and safety of propylthiouracil in psoriasis: An open-label study
    Gnanaraj, Pushpa
    Malligarjunan, Hemamalini
    Dayalan, Haripriya
    Karthikeyan, Subashini
    Narasimhan, Murali
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2011, 77 (06): : 673 - 676
  • [29] Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of trachyonychia: an open-label study
    Park, Jung-Min
    Mun, Je-Ho
    Jwa, Seung-Wook
    Song, Margaret
    Kim, Hoon-Soo
    Ko, Hyun-Chang
    Kim, Byung-Soo
    Kim, Moon-Bum
    JOURNAL OF DERMATOLOGY, 2012, 39 : 48 - 48
  • [30] Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study
    Habibi, N.
    Dodangi, N.
    Efficacy, Nazeri A.
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2015, 40 (06) : 548 - 549
12345